NCT00282360View on ClinicalTrials.gov

Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

February 28, 1999

Study Completion Date

October 31, 2003

Conditions

Coronary Artery DiseaseType II Diabetes Mellitus

Interventions

DRUG

Trimetazidine

All Listed Sponsors

lead

IRCCS San Raffaele

OTHER

NCT00282360 - Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease | Biotech Hunter | Biotech Hunter